BiomX (PHGE) Retained Earnings (2018 - 2026)
BiomX's (PHGE) quarterly Retained Earnings came in at $244.5 million in Q2 2026, up 25.43% year-over-year from $194.9 million in Q2 2025, and up 203.57% quarter-over-quarter from -$236.0 million in Q1 2026.
Analysis
BiomX (PHGE) Retained Earnings (2018 - 2026) Analysis & Trends
BiomX has disclosed Retained Earnings across 9 years of filings, most recently posting $244.5 million for Q2 2026.
- In Q2 2026, Retained Earnings rose 25.43% year-over-year to $244.5 million; the TTM figure through Jun 2026 stood at $244.5 million (up 25.43% YoY), while the FY2025 annual figure was -$216.9 million, down 216.49% from the prior year.
- Retained Earnings came in at $244.5 million for Q2 2026 at BiomX, up from -$236.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $244.5 million in Q2 2026 to a low of -$236.0 million in Q1 2026.
- Average Retained Earnings over 5 years is $85.8 million, with a median of $159.3 million recorded in 2023.
- Year-over-year, Retained Earnings surged 210.85% in 2025 and tumbled 221.54% in 2026.
- Over 5 years, Retained Earnings stood at $157.8 million in 2022, then gained by 5.2% to $166.0 million in 2023, then advanced by 12.13% to $186.2 million in 2024, then sank by 216.49% to -$216.9 million in 2025, then soared by 212.71% to $244.5 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $244.5 million in Q2 2026, -$236.0 million in Q1 2026, and -$216.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 6.57 Bn |
| 10 | BiomX | 1.55 Mn | 7.73 Mn | 97,000.00 | 244.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244.47 Mn |
| Mar 31, 2026 | -236.04 Mn |
| Dec 31, 2025 | -216.90 Mn |
| Sep 30, 2025 | -203.56 Mn |
| Jun 30, 2025 | 194.90 Mn |
| Mar 31, 2025 | 194.20 Mn |
| Dec 31, 2024 | 186.19 Mn |
| Sep 30, 2024 | 185.43 Mn |
| Jun 30, 2024 | -175.83 Mn |
| Dec 31, 2023 | 166.05 Mn |
| Sep 30, 2023 | 165.63 Mn |
| Jun 30, 2023 | 165.44 Mn |
| Mar 31, 2023 | 159.31 Mn |
| Dec 31, 2022 | 157.84 Mn |
| Sep 30, 2022 | 157.47 Mn |
| Jun 30, 2022 | 156.87 Mn |
| Mar 31, 2022 | 156.67 Mn |
| Dec 31, 2021 | 156.02 Mn |
| Sep 30, 2021 | 151.45 Mn |
| Jun 30, 2021 | 136.59 Mn |